Back to Search Start Over

Intestinal Ultrasound Predicts Upadacitinib Efficacy in Patients With Moderate to Severe Crohn's Disease:a Prospective Study.

Source :
Clinical Trials Week; 9/9/2024, p1236-1236, 1p
Publication Year :
2024

Abstract

The article focuses on a clinical trial evaluating intestinal ultrasound (IUS) as a predictor of upadacitinib efficacy in patients with moderate to severe Crohn's disease. Topics include the potential of IUS to predict treatment response, the use of upadacitinib as a JAK-1 inhibitor, and the clinical outcomes associated with its use in Crohn's disease.

Details

Language :
English
ISSN :
15436772
Database :
Complementary Index
Journal :
Clinical Trials Week
Publication Type :
Periodical
Accession number :
179479147